Antibodies Built for Reproducibility

R&D Systems takes antibody reproducibility seriously. We always have. For 30 years we have used our industry-leading production standards and quality control specifications to develop antibodies that can be relied on for quality and reproducibility. With R&D Systems® antibodies your results will stand the test of time.

Results are everything, trust our antibodies.


Ongoing Initiatives in Antibody Validation

International Antibody Validation Meeting

International Antibody
Validation Meeting

R&D Systems is proud to sponsor this unique meeting organized by the University of Bath to bring together scientists from academia, pharma, biotech and antibody suppliers in order to discuss best practices in research antibody validation and help improve antibody validation for the life science community. Bath, UK, September 15-16.

Antibody Validation: Standards, Policies and Practices

Antibody Validation: Standards, Policies and Practices

The Global Biological Standards Institute (GBSI) in conjunction with The Antibody Society will bring together key stakeholders from academia, antibody producers, pharma, funders, and journals to share perspectives and contribute to tangible solutions for validating antibodies. Alisomar Conference Center, Monterey California, Sept 25-27

Development of Validated Monoclonal Antibodies

As a recognized leader in the development and validation of antibodies, R&D Systems has always been committed to producing antibodies that you can trust. A white paper is now available that explains the rigorous validation steps we take to release an antibody.


Our Legacy of Antibody Reproducibility

Webinar: Lessons from 30 Years in Antibody Validation and Reproducibility

Our antibodies continue to get validated through peer-review and are consistently published in high-impact scientific journals.

Exclusive HLDA-Designated Antibodies

39 antibody clones developed by R&D Systems are used as definitive CD markers as designated by the HLDA.
HLDA-qualified CD Markers

Industry-Leading Production Standards

Immunogens are derived from our high-quality proteins. Each antibody is tested for lot-to-lot consistency and antigen specificity. View full product development pipeline.


Our Guarantee


Our antibodies continue to get validated through peer-review and are consistently published in high-impact scientific journals.

Click on the image above for an example of our specificity testing.


New antibody lots are screened by application alongside the previous commercial lots. This ensures that antibody specificity and sensitivity remains consistent from lot-to-lot. Click on the image above for an example of how we ensure antibody consistency.


Detailed information about your antibody is located on its datasheet as well as on our website. This information includes:
• Specificity & cross-reactivity
• Source
• Purification
• Specific immunogen used
• Endotoxin level
• In-house validated applications


In-House Antibody Development and Validation

We have manufactured over 95% of the antibodies offered on our website. In fact, we are one of the only antibody suppliers that still develop antibodies in-house. This means we know the exact history of our antibodies, which makes us uniquely able to authentically guarantee their consistency. Read More.

Screening in Relevant Models

We validate our antibodies in the most biologically relevant system available to us. Click the image above for an example of antibody validation in a relevant biological system.


Our Pledge to You

Product Performance Pledge Guarentee

100% Guarantee

We stand by our antibody reproducibility by offering a 100% Guarantee on their performance.

Customer Service

Expert Technical Support

Our technical support is on-call to answer questions and help you resolve any issue that you may encounter with our antibodies.



We are working with 3rd party organizations to ensure that we are held accountable for the reproducibility of our antibodies.

Novus Affinity Binder

We are sponsoring the Affinity Binder Knockdown Initiative through Antibodypedia, which is using gene silencing to prove antibody specificity. The results are submitted to the initiative and made publicly available on Antibodypedia.

F1000 - Faculty of 1000

Expert Technical Support

R&D Systems supports The Reproducibility Project conducted through the Science Exchange network. This project is dedicated to examining experimental replicability, in particular within the field of cancer biology.